Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-27
Closed -$397 4096
2025
Q3
$397 Buy
27
+12
+80% +$122 ﹤0.01% 3065
2025
Q2
$147 Sell
15
-16
-52% -$132 ﹤0.01% 3416
2025
Q1
$225 Sell
31
-12
-28% -$105 ﹤0.01% 3186
2024
Q4
$336 Buy
+43
New +$354 ﹤0.01% 3039

Other funds holding ETNB

SBI Securities's ETNB Position: Q4 2025 in Review

SBI Securities sold out of 89bio (ETNB) in Q4 2025, closing a stake of 27 shares — an estimated $397 sold.

SBI Securities first reported a position in ETNB in Q4 2024 and held it in 4 quarters. The position peaked at $397 in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • SBI Securities reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • SBI Securities sold 27 89bio shares in Q4 2025, an estimated $397.
  • SBI Securities first reported a position in 89bio in Q4 2024 and held it in 4 quarters.
  • SBI Securities's 89bio position peaked at $397 in Q3 2025.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on SBI Securities's 13F filing for Q4 2025, filed 3 Feb 2026.